CSF2 and cancer: Radiotherapy may cause multiple pro-immunogenic changes within the TME, which convert cancer into an in-situ vaccine via releasing abundant levels of tumor-derived antigens, and GM-CSF was often used as a vaccine adjuvant (24, 25).